{
    "clinical_study": {
        "@rank": "9770", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D3", 
                "arm_group_type": "Experimental", 
                "description": "cholecalciferol 20 \u00b5g per day for 12 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "No Intervention", 
                "description": "Placebo for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to investigate whether a supplementation of 20 \u00b5g Vitamin D3 per\n      day for 12 weeks can be used to normalize vitamin d-Status"
        }, 
        "brief_title": "Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Deficiency of Vitamin D3", 
        "detailed_description": {
            "textblock": "It is the objective of this study to investigate whether a supplementation with Vitamin D3\n      can be used to normalize insufficient vitamin d status and reduce atherosclerotic risk\n      factors such as hypertension, inflammation and hyperlipidemia. The research question is\n      whether Vitamin D3 reduces the level of systemic inflammation and whether Vitamin D3 has an\n      effect on blood lipids."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy volunteers\n\n          -  age between 18 and 70 years\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  use of antihypertensive medication\n\n          -  use of vitamin d or calcium supplements\n\n          -  known renal, inflammatory or malignant diseases\n\n          -  hypercalcemia or hypercalciuria\n\n          -  participation in other clinical studies\n\n          -  use of tanning booths during the study\n\n          -  pregnancy or lactating period"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "107", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711905", 
            "org_study_id": "0315668"
        }, 
        "intervention": {
            "arm_group_label": "Vitamin D3", 
            "description": "daily dosage of 20 \u00b5g Vitamin D3 for 12 weeks", 
            "intervention_name": "Vitamin D3", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "cholecalciferol"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Halle/Saale", 
                    "country": "Germany", 
                    "state": "Sachsen-Anhalt", 
                    "zip": "06120"
                }, 
                "name": "Naturwissenschaftliche Fakult\u00e4t III"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers - a Randomized Trail", 
        "overall_official": {
            "affiliation": "Institut f\u00fcr Agrar- und Ern\u00e4hrungswissenschaften", 
            "last_name": "Gabriele I Stangl, Prof. Dr.", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Ministry of Education and Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "major outcome variable is the increase of 25-hydroxyvitamin D3 in the treatment group in comparison with the placebo group", 
            "measure": "25-hydroxyvitamin D3", 
            "safety_issue": "Yes", 
            "time_frame": "after 12 weeks of supplementation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711905"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Martin-Luther-Universit\u00e4t Halle-Wittenberg", 
            "investigator_full_name": "Ulrike Lehmann", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to reduce atherosclerotic risk factors such as hypertension, inflammation and hyperlipidemia. The research question is whether Vitamin D3 can reduces the level of systemic inflammation and whether Vitamin D3 has an effect on blood lipids.", 
                "measure": "atherosclerotic risk factors", 
                "safety_issue": "Yes", 
                "time_frame": "after 12 weeks of supplementation"
            }, 
            {
                "description": "It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to reduce inflammation as an atherosclerotic risk factor", 
                "measure": "inflammation", 
                "safety_issue": "Yes", 
                "time_frame": "after 12 weeks of supplementation"
            }, 
            {
                "description": "It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to reduce hyperlipidemia as an atherosclerotic risk factor", 
                "measure": "hyperlipidemia", 
                "safety_issue": "Yes", 
                "time_frame": "after 12 weeks of supplementation"
            }
        ], 
        "source": "Martin-Luther-Universit\u00e4t Halle-Wittenberg", 
        "sponsors": {
            "collaborator": {
                "agency": "German Federal Ministry of Education and Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Martin-Luther-Universit\u00e4t Halle-Wittenberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}